


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+8.05%
-1.66%
+1.28%
+9.63%
+1.90%
NVO
Novo Nordisk A/S
$48.24
Latest Comments
November 11, 2025 01:40 PM
Strengths

Trading below its fair value

Upgraded on attractively valued

Investors confidence is positive
Chart
$55.74 (-13.46%)
$56.98 (-15.34%)
$67.7 (-28.74%)
$106.8 (-54.83%)
NVO has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Investors losing confidence

NVO overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Earnings increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Trading below its fair value
![]()
NVO Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
NVO Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayLLY
1024.95
+0.41%
PFE
25.06
-2.83%
LEXX
1.06
-3.64%
VKTX
39.11
+0.28%
MRK
92.92
+0.06%
What is NVO current stock price?
What are NVO stock strengths?
What is NVO Risk Level?
What is NVO market cap and volume?
What is NVO current Stock IQ?
Should I buy NVO stock right now?
Is NVO a Strong Buy right now?
What does a 'Strong Buy' rating mean for NVO?
What does a 'Strong Sell' rating mean for NVO?
What factors influence NVO's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+8.05%
-1.66%
+1.28%
+9.63%
+1.90%
NVO
Novo Nordisk A/S
Current Price
$48.24
Stock Insights
Strengths

Trading below its fair value

Upgraded on attractively valued

Investors confidence is positive
Linked to NVO
LLY
1024.95
+0.41%
PFE
25.06
-2.83%
LEXX
1.06
-3.64%
VKTX
39.11
+0.28%
MRK
92.92
+0.06%

November 11, 2025 01:40 PM
Chart
$55.74 (-13.46%)
$56.98 (-15.34%)
$67.7 (-28.74%)
$106.8 (-54.83%)
NVO Analysts Opinion
NVO Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Earnings increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Trading below its fair value
![]()
NVO Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
NVO Street Sentiment is extremely bullish and have positive views on the near-term outlook
NVO has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Investors losing confidence

Average key support and resistance price levels.
NVO Latest Analysis
Is It Too Late to Buy Novo Nordisk After the Drop?. Novo Nordisk (NYSE: NVO) is in the spotlight after cutting guidance again but analysts remain optimistic. With Ozempic and Wegovy driving strong sales and a 52% upside potential this could be one of the best comeback stories in pharma.
Fri Nov 14, 2025
Team Novo Nordisk announce extended partnership with Novo Nordisk for five additional years. The world'.s first all-diabetes professional cycling team will partner with Global healthcare leader through 2031 announced on World Diabetes DayTeam Novo Nordisk today announced a five-year extension of its partnership with global healthcare leader Novo Nordisk continuing the successful collaboration that led to the creation of the world'.s first all-diabetes professional cycling team. The curr
Fri Nov 14, 2025
Resolutions from the Extraordinary General Meeting of Novo Nordisk A/S. Bagsværd Denmark 14 November 2025 - Today Novo Nordisk A/S held its Extraordinary General Meeting which was convened to elect new members of the Board of Directors.
Fri Nov 14, 2025
Why Is Everyone Talking About Novo Nordisk Stock?. Key PointsNovo Nordisks latest quarterly update disappointed investors -- again.
Fri Nov 14, 2025
RFK Jr. Walks a Tightrope on Trump Deal for Obesity Drugs. Robert F. Kennedy Jr. the health secretary appearing in the Oval Office on Nov. 6 with other health officials the chief executives of Novo Nordisk and Eli Lilly and others.
Fri Nov 14, 2025
Kennedy Walks a Tightrope on Trump Deal for Obesity Drugs. Robert F. Kennedy Jr. the health secretary appearing in the Oval Office on Nov. 6 with other health officials the chief executives of Novo Nordisk and Eli Lilly and others.
Fri Nov 14, 2025
Novo Nordisks leadership strategy tested as shareholders signal frustration ahead of vote on board revamp. Novo Nordisk has found itself in an increasingly chaotic situation as of late with shares plunging and investor confidence waning.
Fri Nov 14, 2025
Novo Nordisk A/S: Candidate for the Board of Directors will not seek election. Today it was announced that Mikael Dolsten will not seek election to the Board of Directors at the upcoming extraordinary general meeting on 14 November
Thu Nov 13, 2025
Novo Nordisk: Long-Term Brand Dominance At A Bargain.
Thu Nov 13, 2025
WeightWatchers to offer Novo Nordisks Wegovy pill after 2026 launch. WeightWatchers CEO said it plans to offer Novo Nordisks much-anticipated Wegovy in pill form if it is launched next year in the United States.
Thu Nov 13, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.